A qualified engineer, CP Rizwan is a technically correct batsman who can also take wickets with his part-time spin
German pharmaceutical giant Merck and a US partner reported promising results on Saturday in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients’ viral load.
“At a time where there is unmet need for antiviral treatments against SARS-CoV-2, we are encouraged by these preliminary data,” said Wendy Painter, chief medical officer of the US firm, Ridgeback Biotherapeutics.
In January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, including a pill-based one called molnupiravir, which it has developed with Ridgeback Biotherapeutics.
This drug caused a significant drop in patients’ viral load after five days of treatment with it, Merck said at a meeting with infectious disease experts.
This Phase 2a test — drug trials have three stages before a product can be approved — was carried out among 202 non-hospitalized people with symptoms of Covid-19.
There was no alert in terms of safety, and of four serious adverse events that were reported, none were considered to be related to taking this drug, Ridgeback said.
Anti-viral oral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza) are sometimes prescribed for seasonal flu but researchers have yet to come up with something similar to fight the coronavirus.
The findings of this study — a quicker decrease in viral load among individuals with early-stage Covid-19 who are treated with molnupiravir — are promising, said William Fischer, lead investigator of the study and a professor of medicine at the University of North Carolina.
“If supported by additional studies, (they) could have important public health implications, particularly as the SARS-CoV-2 virus continues to spread and evolve globally,” Fischer added.
Merck is also working on another oral Covid treatment called MK-711.
Preliminary results from clinical trials with it show a more than 50 percent reduction in risk of death or respiratory trouble in patients hospitalized with moderate to severe Covid-19, the company said in January.
A qualified engineer, CP Rizwan is a technically correct batsman who can also take wickets with his part-time spin
The defeats are a jolt to a full-strength Pakistan side in their preparations for the Twenty20 World Cup
With his famous stepfather Tommy Fleetwood on his bag, Dubai’s Oscar Craig shoots a promising first round 69
Karn Sharma and Swapnil Singh bag four key wickets to secure a 35-run victory in Hyderabad
The patient had endured years of severe pain and debilitating health complications due to the tumour
The concert is set to take place on April 27
Move aims to amplify Zambia’s renewable energy capacity
More vertiports will be set up in strategic locations across Abu Dhabi, including major business hubs and tourism destinations